Complete Pricing Guide for International Patients
China has emerged as a leading destination for international cancer patients seeking high-quality, affordable oncology care. With 5 of the world's top 10 cancer hospitals (according to Nature Index), China offers:
The country's oncology hospitals treat more cancer patients annually than almost anywhere else globally, giving their medical teams unparalleled experience with complex cases. International patients increasingly view China as a viable alternative to prohibitively expensive Western cancer care.
Chemotherapy remains one of the most common cancer treatments, and the cost difference between China and the US is substantial. Chinese hospitals produce many generic chemotherapy drugs domestically, significantly reducing prices.
| Chemotherapy Drug/Type | USA Cost (Per Cycle) | China Cost (Per Cycle) | Savings |
|---|---|---|---|
| General Chemotherapy (Taxane-based) | $10,000-30,000 | $1,500-4,000 | 80-85% |
| Platinum-based (Cisplatin/Carboplatin) | $8,000-20,000 | $1,200-3,500 | 80-85% |
| Targeted Chemotherapy (Anti-angiogenesis) | $15,000-40,000 | $3,000-8,000 | 75-80% |
| Immunochemotherapy (Combined) | $25,000-60,000 | $5,000-12,000 | 75-80% |
Expert Insight: Dr. Wang Xiaoming, Chief Oncologist at Peking Union Medical College Hospital, notes: "Chinese oncology departments have refined chemotherapy protocols over decades of high-volume practice. Our safety records and efficacy rates meet or exceed international standards."
Surgical oncology in China offers the same quality procedures—at a fraction of Western costs. Top Chinese surgeons often perform more surgeries annually than their Western counterparts due to China's large patient population.
| Surgery Type | USA Cost | China Cost | Savings |
|---|---|---|---|
| Breast Cancer (Mastectomy/Lumpectomy) | $50,000-80,000 | $8,000-15,000 | 70-80% |
| Lung Cancer (Lobectomy) | $80,000-150,000 | $15,000-30,000 | 75-80% |
| Colorectal Cancer Surgery | $60,000-100,000 | $12,000-20,000 | 75-80% |
| Liver Cancer (Resection) | $100,000-200,000 | $20,000-40,000 | 75-80% |
| Gastric Cancer (Gastrectomy) | $70,000-120,000 | $14,000-25,000 | 75-80% |
| Thyroid Cancer | $30,000-50,000 | $5,000-10,000 | 75-80% |
Minimally invasive and robotic-assisted surgeries are available at major Chinese cancer centers, often at 60-70% less than US prices for equivalent procedures.
Targeted therapies represent the cutting edge of precision oncology. China has invested heavily in this area and now produces biosimilar versions of many targeted drugs at dramatically lower prices.
| Targeted Therapy | USA Cost (Monthly) | China Cost (Monthly) | Savings |
|---|---|---|---|
| Tyrosine Kinase Inhibitors (Gefitinib, Erlotinib) | $8,000-15,000 | $1,500-3,000 | 75-80% |
| Monoclonal Antibodies (Trastuzumab) | $10,000-20,000 | $2,000-4,000 | 75-80% |
| PARP Inhibitors (Olaparib) | $15,000-25,000 | $3,000-6,000 | 75-80% |
| BTK Inhibitors (Ibrutinib) | $12,000-18,000 | $2,500-5,000 | 70-75% |
| Anti-angiogenesis (Bevacizumab) | $8,000-15,000 | $1,800-3,500 | 75-80% |
"Chinese pharmaceutical advances have made targeted therapies accessible to patients who could never afford them in Western healthcare systems. Genetic testing and personalized treatment planning are now standard at major cancer centers."
— Dr. Li Chen, Director of Precision Oncology, Shanghai Cancer Center
China is a global leader in cancer immunotherapy, with domestically produced PD-1/PD-L1 inhibitors now among the most widely used globally. CAR-T cell therapy is also significantly more affordable in China.
| Immunotherapy Type | USA Cost | China Cost | Savings |
|---|---|---|---|
| PD-1 Inhibitors (Pembrolizumab/Nivolumab) | $150,000/year | $15,000-25,000/year | 80-85% |
| Chinese PD-1 (Sintilimab, Toripalimab, Camrelizumab) | $150,000/year | $10,000-18,000/year | 85-90% |
| CAR-T Cell Therapy (Blood Cancers) | $475,000 | $120,000-150,000 | 70% |
| Combination Immunochemotherapy | $200,000+/year | $30,000-50,000/year | 75-80% |
China has approved multiple domestically-developed PD-1 inhibitors that have shown comparable efficacy to Western alternatives at a fraction of the cost. Clinical trial data published in The Lancet Oncology and Journal of Clinical Oncology supports their effectiveness.
China's leading cancer hospitals combine decades of specialized experience with cutting-edge technology. Here are the top institutions international patients choose:
Established: 1958 | Beds: 2,000+ | Annual Patients: 1.2 million+
Specialties: Lung cancer, gastric cancer, breast cancer, lymphoma, esophageal cancer
Highlights: China's premier cancer center and NCI-designated research institution. Pioneer in immunotherapy clinical trials with over 200 ongoing studies.
International Services: English-speaking staff, dedicated international patient coordinators, JCI-style quality standards
Established: 1936 | Beds: 2,500+ | Annual Patients: 1.4 million+
Specialties: Liver cancer (world leader), colorectal cancer, gastric cancer, pancreatic cancer
Highlights: Performs more liver cancer surgeries than any other center globally. Minimally invasive surgery excellence with robotic da Vinci systems.
International Services: Full English support, JCI accredited, international patient lounge
Established: 1861 | Beds: 2,200+ | Annual Patients: 800,000+
Specialties: Breast cancer, thyroid cancer, bone tumors, head and neck cancers
Highlights: China's first specialized cancer hospital. Advanced breast cancer reconstruction and thyroid cancer treatment protocols.
International Services: International patient services, medical translation
Specialties: Breast cancer, lymphoma, colorectal cancer, genitourinary cancers
Highlights: One of China's first comprehensive cancer centers. Strong research program with international collaborations.
Specialties: Gastrointestinal cancers, breast cancer, lung cancer
Highlights: Leading research in gastrointestinal oncology. Part of Beijing University's medical system.
The following table summarizes typical costs for complete cancer treatment courses in China compared to the United States:
| Treatment Type | USA Cost | China Cost | Your Savings |
|---|---|---|---|
| Radiation Therapy (Full Course) | $50,000-80,000 | $10,000-18,000 | 75-80% |
| Proton Therapy | $150,000 | $40,000-60,000 | 60-70% |
| Full Treatment Course (Lung Cancer) | $150,000-250,000 | $30,000-60,000 | 75-80% |
| Full Treatment Course (Breast Cancer) | $100,000-180,000 | $20,000-40,000 | 75-80% |
| Full Treatment Course (Colorectal) | $120,000-200,000 | $25,000-50,000 | 75-80% |
Not included: Travel, accommodation, meals, and companion expenses.
Initial Diagnosis (USA):
Maria was diagnosed with stage IIIA non-small cell lung cancer at a major US academic medical center. She was recommended concurrent chemoradiation followed by adjuvant immunotherapy.
US Treatment Quote:
Treatment in China:
Maria chose to receive treatment at the Chinese Academy of Medical Sciences Cancer Hospital in Beijing. She traveled with her daughter and was met at the airport by a patient coordinator.
Outcome:
After completing treatment, imaging showed significant tumor response. Maria returned to the US for follow-up monitoring. Her US oncologist noted the treatment protocol was evidence-based and equivalent to standard US care. Total savings: $313,700 (86%), including all travel expenses.
💡 Real Patient Perspective: "The cost difference was staggering. In the US, I was looking at bankruptcy or delayed treatment. In Beijing, I received world-class care immediately. The doctors were fellowship-trained in the US and spoke excellent English. I would make the same choice again." — Maria T.
"China's oncology outcomes have improved dramatically over the past two decades. Five-year survival rates for common cancers now approach Western standards at major treatment centers."
— Dr. Zhang Wei, National Cancer Center of China, CA: A Cancer Journal for Clinicians, 2025
| Cancer Type | USA 5-Year Survival | Top Chinese Centers 5-Year Survival |
|---|---|---|
| Breast Cancer | 90% | 83-90% |
| Colorectal Cancer | 64% | 58-65% |
| Lung Cancer | 22% | 19-25% |
| Liver Cancer | 20% | 25-35% (high-volume centers) |
| Gastric Cancer | 31% | 35-45% |
Connect with China's top oncology specialists and receive a detailed treatment plan with transparent pricing.
Start Free Case Review →Yes. Top Chinese cancer hospitals are JCI accredited and many are ranked among the world's best. Chinese oncologists publish extensively in international journals and participate in global clinical trials. Five-year survival rates at leading Chinese cancer centers now approach or match Western outcomes for most cancer types.
Duration varies by treatment type: Surgery typically requires 2-3 weeks; chemotherapy cycles may span 3-6 months with periodic visits; radiation therapy usually requires 4-6 weeks of daily treatment. Many patients receive initial treatment phases in China and continue maintenance therapy closer to home.
Many international insurance plans cover overseas treatment. We can provide all necessary documentation for insurance claims. Some patients also use medical tourism insurance. Verify coverage with your insurer before making travel arrangements.
No. Major cancer hospitals have dedicated international departments with English-speaking staff. Medical translators are available for consultations and throughout your treatment.
China has particular expertise in liver cancer, gastric cancer, esophageal cancer, and lung cancer due to high domestic prevalence. These cancers are treated with exceptional experience and outcomes at major Chinese cancer centers.
Get a free, no-obligation case review. We'll match you with the right hospital, give honest cost estimates, and answer all your questions — no pressure, no hidden fees.
Start Free Case ReviewOr order our $49 Hospital Match & Plan for a complete pre-trip workbook.
Start with a free case review and get guidance on the right hospital and package for your situation.
Start Free Case Review